Research
Read how they describe their research on their Western University profile.
Latest funding
- $562,275
Assessing the longitudinal outcomes of piperacillin/tazobactam versus ceftriaxone and metronidazole for children with perforated appendicitis (ALPACA): A multicentre randomized controlled trial
CIHR · 2026 · Co-investigator
- $1,143,675
Stem cell extracellular vesicles as a regenerative therapy for hypoplastic lungs: Translational studies in lamb fetuses with congenital diaphragmatic hernia.
CIHR · 2024 · Co-investigator
No publications available.
Assessing the longitudinal outcomes of piperacillin/tazobactam versus ceftriaxone and metronidazole for children with perforated appendicitis (ALPACA): A multicentre randomized controlled trial
Principal investigators: Livingston, Michael
Keywords: Antibiotics; Appendicitis; Pediatrics; Surgery
Stem cell extracellular vesicles as a regenerative therapy for hypoplastic lungs: Translational studies in lamb fetuses with congenital diaphragmatic hernia.
Principal investigators: Zani, Augusto
Keywords: Congenital Diaphragmatic Hernia; Exosomes; Extracellular Vesicles; Fetal Medicine; Fetal Therapy; Lung Development; Pulmonary Hypertension; Pulmonary Hypoplasia; Regenerative Medicine; Stem Cells
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.